These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3670338)

  • 1. Cytogenetic effects of 1-p-(3-methyltriazeno)benzoic acid potassium salt on human lymphocytes in vitro.
    Vernole P; Caporossi D; Tedeschi B; Porfirio B; Melino G; Bonmassar E; Nicoletti B
    Mutat Res; 1987 Nov; 189(3):349-56. PubMed ID: 3670338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sister-chromatid exchanges in human lymphocytes exposed to 1-p-(3-methyltriazeno)benzoic acid potassium salt.
    Vernole P; Caporossi D; Tedeschi B; Melino G; Porfirio B; Bonmassar E; Nicoletti B
    Mutat Res; 1988 Jul; 208(3-4):233-6. PubMed ID: 3398873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of immunological patterns of human cancer cells treated in vitro with a triazene compound.
    D'Atri S; Ballerini P; Fuggetta MP; Faggioni A; Piazza A; Giuliani A
    Immunopharmacol Immunotoxicol; 1989; 11(1):101-18. PubMed ID: 2547862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.
    Beal DD; Skibba JL; Whitnable KK; Bryan GT
    Cancer Res; 1976 Aug; 36(8):2827-31. PubMed ID: 179708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies.
    Nardelli B; Puccetti P; Romani L; Sava G; Bonmassar E; Fioretti MC
    Cancer Immunol Immunother; 1984; 17(3):213-7. PubMed ID: 6566603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-mediated changes in the susceptibility of human lymphoblastoid B cells to NK-mediated cytolysis: studies with a triazene compound.
    D'Atri S; Bonmassar L; Turriziani M; Giuliani A
    J Chemother; 1994 Oct; 6(5):328-36. PubMed ID: 7532216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro combined effects of a triazene compound and interferon-beta on natural immunity against lymphoblastoid cells: studies at effector and target cell level.
    Bonmassar L; D'Atri S; Turriziani M; Giuliani A
    Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):695-715. PubMed ID: 7876468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antitumor activity of 3'-desamino-3'(2-methoxy-4-morpholinyl) doxorubicin on human melanoma cells sensitive or resistant to triazene compounds.
    Alvino E; Gilberti S; Cantagallo D; Massoud R; Gatteschi A; Tentori L; Bonmassar E; D'Atri S
    Cancer Chemother Pharmacol; 1997; 40(2):180-4. PubMed ID: 9182841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attempt to alter antigenic structure of normal tissues by treatment with dimethyl-triazeno-imidazole-carboxamide in vivo.
    Nicolin A; Fagnani R; Nicolotti G; Goldin A
    Experientia; 1976 Jun; 32(6):741-2. PubMed ID: 780128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro lymphocyte stimulation and the generation of cytotoxic lymphocytes with drug-induced antigenic lymphomas.
    Testorelli C; Franco P; Goldin A; Nicolin A
    Cancer Res; 1978 Mar; 38(3):830-4. PubMed ID: 75062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Mizuno NS; Decker RW; Zakis B
    Biochem Pharmacol; 1975 Mar; 24(5):615-9. PubMed ID: 1168474
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide.
    Earl RA; Townsend LB
    J Med Chem; 1979 Nov; 22(11):1422-5. PubMed ID: 533891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G; Giraldi T; Lassiani L; Nisi C
    Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
    Colombo T; D'Incalci M
    Cancer Chemother Pharmacol; 1984; 13(2):139-41. PubMed ID: 6467499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical xenogenization of experimental tumors.
    Puccetti P; Romani L; Fioretti MC
    Cancer Metastasis Rev; 1987; 6(2):93-111. PubMed ID: 3297373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives.
    Nardelli B; Contessa AR; Romani L; Sava G; Nisi C; Fioretti MC
    Cancer Immunol Immunother; 1984; 16(3):157-61. PubMed ID: 6561067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic effects of amsacrine on human lymphocytes in vivo and in vitro.
    Kao-Shan CS; Micetich K; Zwelling LA; Whang-Peng J
    Cancer Treat Rep; 1984; 68(7-8):989-97. PubMed ID: 6204755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E
    Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide [NSC 45388, DTIC] on neuroblastoma cells in culture.
    Culver B; Sahu SK; Vernadakis A; Prasad KN
    Biochem Biophys Res Commun; 1977 Jun; 76(3):778-83. PubMed ID: 20080
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives.
    Puccetti P; Fuschiotti P; Dominici P; Borri-Voltattorni C; Romani L; Fioretti MC
    Int J Cancer; 1987 Jun; 39(6):769-73. PubMed ID: 2438236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.